Visit our foundation to give a gift.
 View Locations Near Me
Main Campus – Hartford
Connecticut Children’s – Waterbury
Urgent Care – Farmington
Specialty Care Center – Danbury
Connecticut Children’s Surgery Center at FarmingtonÂ
Specialty Care Center – Westport
Search All LocationsÂ
Find a doctorÂ
Contact Us Â
Search SpecialtiesÂ
Find A DoctorÂ
Appointments
Locations
Amenities and Services
Who’s Who on Care Team
Getting Ready for Surgery
What to Expect—Picture Stories
Disney Initiative
Pay a Bill
Understanding the Different Fees
Pricing Transparency and Estimates
Child Life
Raytheon Technologies Family Resource Center
Family Advisory Council
Transition Programs
Advocacy
Legal Advocacy: Benefits, Education, Housing
Electronic Health Records
MyChart
Share Your Story
Pay a BillÂ
Login to MyChartÂ
Specialty Referrals
Clinical Support Services Referrals
Inpatient Referrals
ED/Transport Referrals
About the Network
Join the Network
Graduate Medical Education
Continuing Medical Education
MOC/Practice Quality Improvement
Educating Practices in the Community (EPIC)
For Nurses
Learning & Performance
Research
Resources
CLASP Co-Management
Meet our Physician Relations Team
Request Medical Records
Join our Referring Provider Advisory Board
View our Physician Callback Standards
Read & Subscribe to Medical NewsÂ
Register for Email Updates
Update Your Practice Information
Refer a Patient Â
Contact OneCall Â
Physician Assistant, Neonatology
Education MS, Albany Medical College, 2021
Rebecca Pappalardo, PA-C, is a physician assistant in the Division of Neonatology at Connecticut Children’s. Rebecca is a former 29-week premature triplet born at Connecticut Children’s, and she’s always been passionate to give back to the hospital that saved her life. Rebecca’s clinical interests include stem cell based therapies. In her free time, she enjoys collecting antique novels, hiking, astronomy and writing poetry.
Levesque AA, Pappalardo RM, Puli P, Enzor LA, Angeles C (2022) p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitor. PLoS ONE 17(2): e0263463